Aegon: Credit Suisse changes to 'buy'

(CercleFinance.com) - In a sectoral note on Benelux insurers, Credit Suisse changes to 'buy' (outperform) on the share of Aegon, on which analysts were previously neutral.
Passing from 4.5 to 5.4 euros, the target price promises a rise of 17%.

The analysts' firm crunched numbers under the angle of the Solvency II standards applicable in 2020. The impact will be negative for a certain number of shares but "our analysis suggests that it is not a major threat to the sector's dividend or growth potential" says Credit Suisse.

Aegon distinguishes itself for its vast portfolio of activities which "makes it relatively insensitive to the review" indicates a note that also brings to the fore its cash-flow generation. This is because the Dutch group has just come out of a restructure that has greatly improved its risk profile. The group's American subsidiaries are judged solid.

Copyright (c) 2019 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.